--- title: "Sahajanand Medical Technologies (SMT) Share Price, Financials & Research" symbol: "SMT" company: "Sahajanand Medical Technologies" canonical: "https://tapetide.com/stocks/SMT" isin: "INE356Y01018" nse_symbol: "SMT" generated_at: "2026-11-05T01:44:21.677Z" --- # Sahajanand Medical Technologies (SMT) Canonical page: https://tapetide.com/stocks/SMT ## Key Facts - **Price:** ₹485.90 as of 4 Nov 2026, 15:56 IST - **P/E (TTM):** 323.93 as of 4 Nov 2026 - **Promoter holding:** 44.97% in Sep 2021 ## Company - **NSE symbol:** SMT - **ISIN:** INE356Y01018 - **In the F&O segment:** No ## Latest Price - **Price:** ₹485.90 - **Change:** No trade today - **Previous Close:** ₹485.90 - **As of:** 4 Nov 2026, 15:56 IST ## Key Fundamentals Price-based figures as of 4 Nov 2026, 15:56 IST · TTM. - **ROCE:** 13.30% - **EPS (TTM):** ₹1.50 - **Book Value:** ₹68.45 - **P/E (TTM):** 323.93 - **P/B:** 7.10 - **ROE:** 9.84% - **Dividend Yield:** 0.00% - **52W High:** ₹565.75 - **52W Low:** ₹346.65 ## Technical Indicators As of 4 Nov 2026. | Group | Signal | Bearish | Neutral | Bullish | | --- | --- | ---: | ---: | ---: | | Overall | Neutral | 0 | 19 | 0 | | Oscillators | Neutral | 0 | 9 | 0 | | Moving Averages | Neutral | 0 | 10 | 0 | ### Oscillators: Neutral | Name | Value | Signal | | --- | ---: | --- | | RSI (14) | — | Neutral | | MACD (12,26,9) | — | Neutral | | Stochastic (14,3,3) | — | Neutral | | ADX (14) | — | Neutral | | Williams %R (14) | — | Neutral | | ATR (14) | — | Neutral | | ROC (12) | — | Neutral | | Stoch RSI (14) | — | Neutral | | UO (7,14,28) | — | Neutral | ### Moving Averages: Neutral | Name | Value | Signal | | --- | ---: | --- | | SMA (10) | — | Neutral | | EMA (10) | — | Neutral | | SMA (20) | — | Neutral | | EMA (20) | — | Neutral | | SMA (50) | — | Neutral | | EMA (50) | — | Neutral | | SMA (100) | — | Neutral | | EMA (100) | — | Neutral | | SMA (200) | — | Neutral | | EMA (200) | — | Neutral | ### Pivot Points | Level | Classic | Fibonacci | Camarilla | | --- | ---: | ---: | ---: | | R3 | 555.44 | 527.67 | 499.28 | | R2 | 527.67 | 509.09 | 494.82 | | R1 | 506.79 | 497.60 | 490.36 | | PP | 479.02 | 479.02 | 479.02 | | S1 | 458.14 | 460.44 | 481.44 | | S2 | 430.37 | 448.95 | 476.98 | | S3 | 409.49 | 430.37 | 472.52 | ## Financial Statements No financial statements are available for this company yet. ## Shareholding Pattern The latest pattern on file is for Sep 2021; it may not describe the holding today. ### Quarterly Shareholding Holdings in % of shares; shareholders as a count. | Holder | Sep 2021 | | --- | ---: | | Promoters | 44.97% | | FIIs | 0.00% | | DIIs | 0.00% | | Government | 0.00% | | Public | 0.00% | | Others | 55.03% | | No. of Shareholders | 8 | ## Documents ### Exchange filings | Date | Document | Category | | --- | --- | --- | | 27 Oct 2026 | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05CDD854_20AD_4707_909B_A93ECA657545_105127.pdf) | General | | 27 Oct 2026 | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7D606388_4C59_4F10_BDC6_A96EF6193D35_105955.pdf) | General | | 26 Oct 2026 | [Board Meeting Intimation for Consideration Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th September 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ab30a3b-d6c9-45d2-80d4-e88080143bf9.pdf) | Intimation | | 26 Oct 2026 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c360bb11-3b03-4d3d-9d50-ed5df8283ef8.pdf) | General announcements | | 24 Oct 2026 | [Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e622061-d78b-4108-8526-7a60680bc2f4.pdf) | General announcements | | 23 Oct 2026 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cad17d0a-3693-4e0a-98bf-5f8775be00d6.pdf) | Intimation | | 23 Oct 2026 | [Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c0df831-ed36-425d-bd62-effe0aa14fb3.pdf) | General announcements | | 23 Oct 2026 | [Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f86f44c-e157-49d8-bc2a-cb9a35082772.pdf) | General announcements | | 23 Oct 2026 | [Intimation Under Regulation 6(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c923523-7f4b-4804-9bc5-f80660a97d2b.pdf) | General announcements | ## Frequently Asked Questions about Sahajanand Medical Technologies ### Where is Sahajanand Medical Technologies (SMT) listed? Sahajanand Medical Technologies trades as SMT on the NSE. ### What is the PE ratio of Sahajanand Medical Technologies? Sahajanand Medical Technologies trades at a PE ratio of 323.93 as of 4 Nov 2026, on earnings per share of ₹1.5, against a book value of ₹68.45 per share. ### What is the 52-week high and low of Sahajanand Medical Technologies? Over the last 52 weeks Sahajanand Medical Technologies has traded between ₹346.65 and ₹565.75 as of 4 Nov 2026. ### What is the Return on Equity (ROE) of Sahajanand Medical Technologies? Sahajanand Medical Technologies reported a return on equity of 9.84%. ## Company Information - **Listed:** 23 Oct 2026 --- Negative figures use an ASCII hyphen-minus (-) so they parse as numbers. Amounts are in Indian rupees; "Cr" is crore (10 million). Dates are Indian Standard Time. Financial statements, shareholding and filings are as reported by the company. Price, volume and 52-week levels are market data. Technical indicators are computed by Tapetide from daily prices. The Tapetide Score is Tapetide’s own analysis. Analyst ratings and forecasts are the published estimates of third-party analysts, not company statements. The AI sections are generated text. For research and information only, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser. Generated 5 Nov 2026, 07:14 IST.